Ovarian Cancer Trial, Recruiting NCT07039331 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT07039331
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman aged 18 or older
  • You have been diagnosed (confirmed by lab testing of tissue or cells) with a specific type of ovarian cancer, primary peritoneal cancer, or fallopian tube cancer that cannot be treated with surgery first, but can be treated with chemotherapy before surgery
  • Your cancer is at an advanced stage (Stage III or IV)
  • You have not received any previous treatment for your ovarian cancer
  • Your Body Mass Index (BMI — a measure of body weight relative to height) is 19 or above
  • Your general health and ability to carry out daily activities falls within an acceptable range as measured by a standard medical scale (confirm with trial site)
  • You are expected to live for more than 3 months
  • Your blood cell counts, liver function, kidney function, and protein levels in your blood are within acceptable ranges as determined by blood tests (confirm with trial site)
  • You are able to attend all required treatment appointments and follow-up visits
  • You are willing and able to sign a consent form agreeing to take part in the trial
  • If you are able to become pregnant, you are willing to use effective contraception during treatment and for 3 months after, unless you have gone through menopause or have had a surgical procedure that means you cannot become pregnant
  • You have a confirmed negative pregnancy test before joining the trial

Who may not be able to join:

  • You have had another serious cancer diagnosis within the past 5 years
  • You have diabetes
  • You have had a heart attack, stroke, or blood clot in the lungs within the last 3 months
  • You have a heart rhythm problem that is not well controlled with medication (note: some types of irregular heartbeat, such as atrial fibrillation, may still be acceptable — confirm with trial site)
  • You have a serious active infection or other active serious illness affecting your whole body
  • You have an active hepatitis virus infection or active HIV infection (note: having positive blood results without symptoms may not automatically exclude you — confirm with trial site)
  • You have significant heart failure as classified by a standard medical scale (confirm with trial site)
  • You are currently pregnant or breastfeeding
  • You have serious food allergies that would prevent you from eating the food provided as part of the trial
  • You have a history of, or currently have, an eating disorder
  • You have limited physical mobility that affects your ability to move around

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Claudia Marchetti, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: 0630158556

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
7 December 2021
Est. completion
1 April 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

The effects of short-term fasting and free diet on ovarian cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov